openPR Logo
Press release

Cytotoxic Drugs Market Trends, Growth, Industry Analysis and Forecast - 2025

07-25-2020 02:36 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Cytotoxic Drugs Market

Cytotoxic Drugs Market

The global cytotoxic drugs market is estimated to grow at a CAGR of nearly 1.3% during the forecast period. Significant rise in cancer incidences has led the demand for chemotherapy which utilizes specialized medications to reach and kill cancer cells in a part of the body, rather than surgery and radiation, which target particular areas. As per the World Health Organization (WHO), in 2018, the cancer burden across the globe is anticipated to have increased to 18.1 million new incidences and 9.6 million mortalities. Globally, one in 5 men and one in 6 women develop cancer in their lifetime. Globally, 43.8 million patients were suffering from cancer in 2018.

Get Sample Copy of Cytotoxic Drugs Market at: https://www.omrglobal.com/request-sample/cytotoxic-drugs-market

The major players operating in the market include Pfizer Inc., Mylan N.V., Johnson & Johnson Services, Inc., F. Hoffman La-Roche AG, and Bristol Myers Squibb Co.

Chemo is regarded as a systemic treatment as the drugs travel in all over the body and kill cancerous cells that have spread to body parts far away from the primary tumor, which makes it different from other cancer treatments such as radiation and surgery. Surgery is used for tumor removal from a body part where cancer has been detected. Radiation therapy is intended at a certain area of the body to damage or kill cancerous cells. These are known as local treatments as they affect one part of the body. Chemotherapy involves the use of cytotoxic drugs to kill cancer cells. These drugs restrict the division of cells and thereby kills cancerous cells. The therapy can be potential outside the primary tumor as well as destroy small tumors that have not been identified in tests.

For More Information, get A full report of Cytotoxic Drugs Market is available at: https://www.omrglobal.com/industry-reports/cytotoxic-drugs-market

Several kinds of cytotoxic drugs are utilized in cancer therapy and the professionals administer a combination of multiple different cytotoxic drugs. The chemotherapy effectiveness relies on the kind of tumor, tumor development rate and its composition, as well as the proportion of cells in the distribution stage. Owing to the potential role of cytotoxic drugs in chemotherapy, the pharmaceutical companies are focusing on launching new cytotoxic drugs for more reliable and effective treatment of cancer diseases. For instance, in April 2020, Intensity Therapeutics signed a clinical trial partnership agreement with Bristol Myers Squibb Co. This program aims to assess the safety and efficacy of the lead product of Intensity referred to as INT230-6. It is a new anti-cancer drug under investigation which is intended to directly kill cancerous cells with intratumoral injection.

In addition, it aims to improve immune cell recognition of cancer, while offered in combination with Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) immune checkpoint inhibitor Yervoy (ipilimumab) of Bristol Myers Squibb. This combination will be assessed among patients suffering from advanced sarcoma, liver cancer, and breast cancer, in a range of new cohorts under IT-01, current Phase 1/2 clinical trial of Intensity. Bristol Myers Squibb will supply Yervoy for the study and Intensity will sponsor and conduct the clinical trial. Such kinds of clinical studies will offer an opportunity for the introduction of combined therapies for the treatment of cancer, which in turn, will likely drive the global cytotoxic drugs market.

Global Cytotoxic Drugs Market- Segmentation

By Drug Class

Alkylating
Antimetabolites
Antitumor Antibiotics
Plant Alkaloids
Others

By Application

Lung Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Others
Global Cytotoxic Drugs Market– Segment by Region

North America

US
Canada

Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Latin America
The Middle East and Africa


For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/cytotoxic-drugs-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cytotoxic Drugs Market Trends, Growth, Industry Analysis and Forecast - 2025 here

News-ID: 2096744 • Views: 158

More Releases from Orion Market Research

Hydrogen Fuel Cell Electric Vehicles Market Trends, Business Overview, Industry …
The global hydrogen fuel cell electric vehicles market is anticipated to grow at a significant CAGR of 18.1% during the forecast period (2022-2028). Increased environmental concerns, supportive government initiatives for the development of hydrogen fuel cell infrastructure, rising infrastructural development investments, and technological advancement are some of the important factors influencing the growth of the global hydrogen fuel cell electric vehicles market. As public awareness of environmental damage and natural resource
US Direct Carrier Billing Platform Market Trends, Business Overview, Industry Gr …
The US direct carrier billing platform market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The direct carrier billing platform is an internet-based payment system in which the payment is made via the internet. The rise of the direct carrier billing platform market is attributed to the rising demand and adoption of subscription-based digital content, rising internet penetration in the US, and an increasing level
Automotive Signaling Wire Market Trends, Business Overview, Industry Growth and …
The global automotive signaling wire market is anticipated to grow at a significant CAGR of 6.4% during the forecast period (2022-2028). An automotive signaling wire is an assembly of wires and cables, which transmit electric power and signals. The increased vehicle penetration and the growth in preference for having a smart communication system installed in the automotive vehicle are boosting the growth of the global automotive signaling wire market. The
Pickup Tonneau Covers Market Trends, Business Overview, Industry Growth and Fore …
The global pickup tonneau covers market is anticipated to grow at a significant CAGR of 4.4% during the forecast period (2022-2028). The global pickup tonneau covers market is growing due to increasing demand for premium convertible cars and pickup trucks. The average life of vehicles and components is increasing as a result of technical improvements, creating market demand. Hard tonneau covers are expected to become more popular as the demand for

All 5 Releases


More Releases for Cytotoxic

Cytotoxic Drugs Market expands the frontiers of medical research
Cytotoxic, the name implies an agent or process that is toxic to cells. Cytotoxic Drugs are also known as anti-cancer drugs. These drugs work by interrupting cell growth at particular phases in the growth cycle. It works inhibiting the growth of cells that are growing rapidly, for example cancer cells. Its mechanism of action involves weakening of the cell membrane which leads to lysis of the cell i.e. it explodes.
Cytotoxic Drugs Market Intelligence and Analysis for Period (2016-2026)
Cytotoxic, the name implies an agent or process that is toxic to cells. Cytotoxic Drugs are also known as anti-cancer drugs. These drugs work by interrupting cell growth at particular phases in the growth cycle. It works inhibiting the growth of cells that are growing rapidly, for example cancer cells. Its mechanism of action involves weakening of the cell membrane which leads to lysis of the cell i.e. it explodes.
Cytotoxic Drugs Market Trends and Segments 2016-2026
Cytotoxic, the name implies an agent or process that is toxic to cells. Cytotoxic Drugs are also known as anti-cancer drugs. These drugs work by interrupting cell growth at particular phases in the growth cycle. It works inhibiting the growth of cells that are growing rapidly, for example cancer cells. Its mechanism of action involves weakening of the cell membrane which leads to lysis of the cell i.e. it explodes.
Cytotoxic Drug Global Market Overview and Analysis 2017
Report Bazzar has released its latest research-based report entitled ‘Cytotoxic Drug market.' This comprehensive report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Cytotoxic Drug Market worldwide along with the key trends and latest technologies, playing a prominent role in the Cytotoxic Drug market growth over the predicted period. It also takes into account the market trends,
Cytotoxic Drugs Market Size, Analysis, and Forecast Report 2016-2026
Cytotoxic, the name implies an agent or process that is toxic to cells. Cytotoxic Drugs are also known as anti-cancer drugs. These drugs work by interrupting cell growth at particular phases in the growth cycle. It works inhibiting the growth of cells that are growing rapidly, for example cancer cells. Its mechanism of action involves weakening of the cell membrane which leads to lysis of the cell i.e. it explodes.
Global Prostate Cancer Market 2016: Chemotherapy, Cytotoxic drugs, Hormonal Ther …
The global prostate cancer market is poised to grow at an exponential pace, primarily due to the mounting prevalence of Prostate cancer, rapidly aging population and strong bolstering pipeline. The market would undergo a transformation during the analysis period, attributed by emerging product launches and line extensions opted for existing therapies. Limited treatment options along with a booming patient pool has generated the need for novel effective therapies with enhanced